G9133
HCPCSOnc dx prostate clinical met
Official HCPCS Level II long descriptor
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)
HCPCS Level II code G9133 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx prostate clinical met
Added to HCPCS: 2007-01-01
Nearby codes in G9
- G9124Onc dx cml acceler phase
- G9125Onc dx cml blast phase
- G9126Onc dx cml remission
- G9128Onc dx multi myeloma stage i
- G9129Onc dx mult myeloma stg2 hig
- G9130Onc dx multi myeloma unknown
- G9131Onc dx brst unknown nos
- G9132Onc dx prostate mets no cast
- G9134Onc nhlstg 1-2 no relap no
- G9135Onc dx nhl stg 3-4 not relap
- G9136Onc dx nhl trans to lg bcell
- G9137Onc dx nhl relapse/refractor
- G9138Onc dx nhl stg unknown
- G9139Onc dx cml dx status unknown
- G9140Frontier extended stay demo
- G9143Warfarin respon genetic test
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.